Journal article
The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation
L Hsin, NA Fernandopulle, J Ding, C Lumb, N Veldhuis, JA Karas, SE Northfield, GA Mackay
Pharmacology Research and Perspectives | Published : 2022
DOI: 10.1002/prp2.990
Abstract
The tachykinin neuropeptide substance P (SP) is the canonical agonist peptide for the neurokinin 1 receptor (NK1R). More recently, it has also been shown to activate the Mas-related G protein-coupled receptor X2 (MRGPRX2) receptor on mast cells (MCs), triggering degranulation and release of inflammatory mediators. SP undergoes rapid C-terminal truncation in vivo by a number of proteases to generate the metabolites SP(1–9)-COOH and in particular SP(1–7)-COOH. While the C terminus of SP is critical for NK1R activation, studies have shown that the peptide polycationic N terminus is key for MRGPRX2 and mast cell activation. The study thus aimed to determine if the C-terminally truncated metaboli..
View full abstractGrants
Funding Acknowledgements
Australian and New Zealand College of Anesthetists